Picture of Immuron logo

IMC — Immuron News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Australia's Immuron rises as company seeks partnership for new drug

BUZZ-Australia's Immuron rises as company seeks partnership for new drug

** Shares of Australia's Immuron IMC.AX rise 11.1% to A$0.040, hitting their highest level since June 4

** Stock marks its biggest intraday pct gain since June 1

** The biopharmaceutical company says it is employing an advisory firm to help seek a partner to support clinical and commercial development of IMM-529

** The IMM-529 is a product that can treat/prevent Clostridioides difficile infection, a contagious bacterial infection of the large intestine

** Immuron stock up 11.1%, YTD



(Reporting by Shravya Marakini in Bengaluru)

((shravya.marakini@thomsonreuters.com;))

Recent news on Immuron

See all news